Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15285 | 721 | 43.3 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
1167 | 2 | GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN | 9383 |
15285 | 1 | GPR40//GPR120//GPR119 | 721 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GPR40 | authKW | 3849202 | 14% | 87% | 104 |
2 | GPR120 | authKW | 1937940 | 8% | 80% | 57 |
3 | GPR119 | authKW | 1473035 | 6% | 87% | 40 |
4 | GPR43 | authKW | 1079278 | 4% | 88% | 29 |
5 | GPR119 AGONIST | authKW | 891190 | 3% | 96% | 22 |
6 | FFAR1 | authKW | 747048 | 3% | 84% | 21 |
7 | FFA1 | authKW | 635251 | 2% | 100% | 15 |
8 | GPR40 AGONIST | authKW | 465851 | 2% | 100% | 11 |
9 | FFAR4 | authKW | 435597 | 2% | 86% | 12 |
10 | GPR41 | authKW | 406556 | 2% | 80% | 12 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 2667 | 18% | 0% | 133 |
2 | Endocrinology & Metabolism | 2013 | 21% | 0% | 152 |
3 | Pharmacology & Pharmacy | 821 | 21% | 0% | 155 |
4 | Biochemistry & Molecular Biology | 388 | 23% | 0% | 164 |
5 | Cell Biology | 228 | 11% | 0% | 79 |
6 | Chemistry, Organic | 189 | 9% | 0% | 64 |
7 | Nutrition & Dietetics | 175 | 5% | 0% | 34 |
8 | Physiology | 104 | 5% | 0% | 37 |
9 | Biophysics | 89 | 5% | 0% | 37 |
10 | Agriculture, Dairy & Animal Science | 28 | 2% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GENOM DRUG DISCOVERY SCI | 141452 | 3% | 16% | 21 |
2 | LOMONOSOV FINE CHEM TECHNOL | 127050 | 0% | 100% | 3 |
3 | PHYSIOL SURUGA KU | 95286 | 0% | 75% | 3 |
4 | MOL PHARMACOL GRP | 91270 | 4% | 7% | 29 |
5 | GENOM HISTOL | 84700 | 0% | 100% | 2 |
6 | TARGET BIOINFORMAT EUROPE | 84700 | 0% | 100% | 2 |
7 | METAB DIS DRUG DISCOVERY UNIT | 76228 | 0% | 60% | 3 |
8 | MOL CELL SYST BIOL | 69509 | 4% | 6% | 29 |
9 | MOL MED THER Y | 58812 | 1% | 28% | 5 |
10 | GYEONG GI BIO | 56465 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACS MEDICINAL CHEMISTRY LETTERS | 6022 | 2% | 1% | 14 |
2 | FRONTIERS IN ENDOCRINOLOGY | 4641 | 1% | 1% | 8 |
3 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2643 | 6% | 0% | 40 |
4 | DIABETES OBESITY & METABOLISM | 1907 | 1% | 0% | 10 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 1508 | 4% | 0% | 28 |
6 | ANNUAL REPORTS IN MEDICINAL CHEMISTRY | 1181 | 1% | 1% | 5 |
7 | MOLECULAR PHARMACOLOGY | 712 | 2% | 0% | 13 |
8 | BMC PHARMACOLOGY & TOXICOLOGY | 653 | 0% | 1% | 2 |
9 | BIOORGANIC & MEDICINAL CHEMISTRY | 616 | 2% | 0% | 14 |
10 | DIABETES | 575 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GPR40 | 3849202 | 14% | 87% | 104 | Search GPR40 | Search GPR40 |
2 | GPR120 | 1937940 | 8% | 80% | 57 | Search GPR120 | Search GPR120 |
3 | GPR119 | 1473035 | 6% | 87% | 40 | Search GPR119 | Search GPR119 |
4 | GPR43 | 1079278 | 4% | 88% | 29 | Search GPR43 | Search GPR43 |
5 | GPR119 AGONIST | 891190 | 3% | 96% | 22 | Search GPR119+AGONIST | Search GPR119+AGONIST |
6 | FFAR1 | 747048 | 3% | 84% | 21 | Search FFAR1 | Search FFAR1 |
7 | FFA1 | 635251 | 2% | 100% | 15 | Search FFA1 | Search FFA1 |
8 | GPR40 AGONIST | 465851 | 2% | 100% | 11 | Search GPR40+AGONIST | Search GPR40+AGONIST |
9 | FFAR4 | 435597 | 2% | 86% | 12 | Search FFAR4 | Search FFAR4 |
10 | GPR41 | 406556 | 2% | 80% | 12 | Search GPR41 | Search GPR41 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MILLIGAN, G , SHIMPUKADE, B , ULVEN, T , HUDSON, BD , (2017) COMPLEX PHARMACOLOGY OF FREE FATTY ACID RECEPTORS.CHEMICAL REVIEWS. VOL. 117. ISSUE 1. P. 67 -110 | 219 | 60% | 2 |
2 | LI, Z , QIU, QQ , GENG, XQ , YANG, JY , HUANG, WL , QIAN, H , (2016) FREE FATTY ACID RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES: DRUGS IN PRECLINICAL TO PHASE II CLINICAL DEVELOPMENT.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 25. ISSUE 8. P. 871 -890 | 84 | 75% | 3 |
3 | WATTERSON, KR , HUDSON, BD , ULVEN, T , MILLIGAN, G , (2014) TREATMENT OF TYPE 2 DIABETES BY FREE FATTY ACID RECEPTOR AGONISTS.FRONTIERS IN ENDOCRINOLOGY. VOL. 5. ISSUE . P. - | 77 | 86% | 20 |
4 | RITTER, K , BUNING, C , HALLAND, N , POVERLEIN, C , SCHWINK, L , (2016) G PROTEIN-COUPLED RECEPTOR 119 (GPR119) AGONISTS FOR THE TREATMENT OF DIABETES: RECENT PROGRESS AND PREVAILING CHALLENGES.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 8. P. 3579 -3592 | 64 | 89% | 3 |
5 | MILLIGAN, G , ALVAREZ-CURTO, E , WATTERSON, KR , ULVEN, T , HUDSON, BD , (2015) CHARACTERIZING PHARMACOLOGICAL LIGANDS TO STUDY THE LONG-CHAIN FATTY ACID RECEPTORS GPR40/FFA1 AND GPR120/FFA4.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 172. ISSUE 13. P. 3254 -3265 | 68 | 85% | 12 |
6 | HARA, T , KIMURA, I , INOUE, D , ICHIMURA, A , HIRASAWA, A , (2013) FREE FATTY ACID RECEPTORS AND THEIR ROLE IN REGULATION OF ENERGY METABOLISM.REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 164. VOL. 164. ISSUE . P. 77-116 | 84 | 71% | 23 |
7 | MANCINI, AD , POITOUT, V , (2015) GPR40 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES: LIFE AFTER 'TAKING' A HIT.DIABETES OBESITY & METABOLISM. VOL. 17. ISSUE 7. P. 622 -629 | 60 | 77% | 21 |
8 | YONEZAWA, T , KURATA, R , YOSHIDA, K , MURAYAMA, MA , CUI, XF , HASEGAWA, A , (2013) FREE FATTY ACIDS-SENSING G PROTEIN-COUPLED RECEPTORS IN DRUG TARGETING AND THERAPEUTICS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 31. P. 3855-3871 | 78 | 64% | 31 |
9 | MOHAMMAD, S , (2016) GPR40 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS: BENEFITS AND CHALLENGES.CURRENT DRUG TARGETS. VOL. 17. ISSUE 11. P. 1292 -1300 | 71 | 77% | 0 |
10 | HARA, T , KASHIHARA, D , ICHIMURA, A , KIMURA, I , TSUJIMOTO, G , HIRASAWA, A , (2014) ROLE OF FREE FATTY ACID RECEPTORS IN THE REGULATION OF ENERGY METABOLISM.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1841. ISSUE 9. P. 1292 -1300 | 62 | 70% | 36 |
Classes with closest relation at Level 1 |